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DOI 10.1016/j.stem.2007.12.013To date, the derivation of all human em-
bryonic stem cell (hESC) lines has involved
destruction of embryos. We previously
demonstrated that hESCs can be gener-
ated from single blastomeres (Kliman-
skaya et al., 2006). In that ‘‘proof-of-princi-
ple’’ study, multiple cells were removed
from each embryo and none of the em-
bryos were allowed to continue develop-
ment. Here we report the derivation of
five hESC lines without embryo destruc-
tion, including one without hESC cocul-
ture. Single blastomeres were removed
from the embryos by using a technique
similar to preimplantation genetic diagno-
sis (PGD). The biopsied embryos were
grown to the blastocyst stage and frozen.
The blastomeres were cultured by using
a modified approach aimed at recreating
the ICM niche, which substantially im-
proved the efficiency of the hESC deriva-
tion to rates comparable to whole embryo
derivations. All five lines maintained nor-
mal karyotype and markers of pluripo-
tency for up to more than 50 passages
and differentiated into all three germ
layers.
Although Thomson et al. (1998) first re-
ported the derivation of hESCs in 1998,
the need to destroy or disaggregate em-
bryos (Cowan et al., 2004; Hovatta et al.,
2003; Klimanskaya et al., 2005; Lanzen-
dorf et al., 2001; Reubinoff et al., 2000)
continues to cause ethical concerns and
is prohibited by law in many countries. In
the United States, federal funding is not
permitted for research that involves the
destruction of human embryos or the
use of hESC lines derived from those em-
bryos (Dickey-Wicker, 1996).
The strategy we employed previously
for derivation of hESCs from single blasto-
meres (Klimanskaya et al., 2006) fre-quently led to the formation of trophecto-
dermal-like vesicles that formed small
sheets of cells with trophoblastic mor-
phology similar to that described in previ-
ous studies (Geber et al., 1995; Rossant,
1976; Takeuchi et al., 2007; Wilton and
Trounson, 1989) This procedure was,
therefore, highly inefficient (only 2%
of blastomeres generated hESC lines),
and multiple biopsies were taken from
each embryo to minimize the number of
embryos destroyed in the experiment.
To increase the efficiency of hESC deriva-
tion, in this study we employed a modified
approach aimed at recreating the ICM
niche by preventing trophectoderm differ-
entiation.
A series of nine initial experiments sep-
arated into two groups were carried out
with pronuclear stage embryos that were
thawed and cultured to the eight-cell
stage (Table S1 available online). As in
PGD, only one (or in a few [7/41] cases,
two) blastomere was removed from
each embryo by using a biopsy proce-
dure. For both groups, the derivation pro-
cess included coculture with GFP-labeled
hESCs. In the first set of experiments, the
parental embryos and blastomeres were
cultured together in the original microdrop
for 12 to 24 hr, and then the parental em-
bryos were transferred to blastocyst me-
dium for an additional 48 hr. 22 of the 26
biopsied embryos (85%) continued devel-
opment to the blastocyst stage, and most
(21/31) of the single blastomeres divided,
forming either cell clumps or vesicles
comprising four to eight cells. They were
transferred to microdrops of blastocyst
medium supplemented with laminin and
fibronectin and seeded with mitotically in-
activated mouse embryonic fibroblasts
(MEFs). The following day, the microdropsCell Stem Cewere merged with GFP-hESC-seeded
microdrops as described in the Supple-
mental Experimental Procedures. Under
these conditions, the vast majority of sin-
gle-blastomere-derived cell aggregates
formed cavitated trophectodermal-like
vesicles. Vesicles that did not attach
spontaneously within 28 hr after plating
were forced to attach by poking them
with a 26 G needle. Only 1 out of 26 biop-
sied embryos generated an hESC line
(no embryo destruction [NED1]) with this
method.
In the second set of experiments, the
parental embryos and biopsied blasto-
meres were only cocultured together
for 12 hr before transfer of the blasto-
meres to blastocyst medium microdrops
supplemented with laminin and fibro-
nectin. Importantly, trophectodermal-like
vesicles did not form under these condi-
tions, but almost all (9/11) blastomere-
derived cell aggregates produced out-
growths that had either an ESC-like or
nontrophoblast cell morphology. In both
sets of experiments, the parental
embryos were allowed to develop to
the blastocyst stage and frozen. 80%–
85% of the biopsied embryos formed
healthy blastocysts (Table S1 and Fig-
ure 1B, row a), a rate consistent with
or higher than previously reported for
both biopsied and nonbiopsied embryos
(Geber and Sampaio, 1999; Palmer et al.,
2002).
29 of the 32 (91%) blastomere-derived
aggregates generated cellular outgrowths,
of which 4/20 (20%) and 4/9 (44%) mor-
phologically resembled hESCs in the first
and second sets of experiments, respec-
tively (Table S1 and Figure 1A). In the first
set of experiments, only 1 of the 26 em-
bryos (3.8%) generated a stable hESCll 2, February 2008 ª2008 Elsevier Inc. 113
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CorrespondenceFigure 1. Derivation and Characterization of hESC Lines from Single Blastomeres without Embryo Destruction
(A) Stages of derivation of hES cells from single blastomere. (a) Blastomere biopsy, (b) biopsied blastomere (arrow) and parent embryo are developing next to
each other, (c) initial outgrowth of single blastomere on MEFs, 6 days, and (d) colony of single blastomere-derived hES cells.
(B) Blastocysts formed by the biopsied parental embryos (a) and markers of pluripotency in single blastomere-derived hES cell lines (b–i); (b) alkaline phospha-
tase, (c) Oct-4, (d) DAPI corresponding to Oct-4 and Nanog (e), (f) SSEA-3, (g) SSEA-4, (h) TRA-1-60, and (i) TRA-1-81.
(C) Differentiation of single-blastomere-derived hESCs into three germ layers in vivo (a–d) and in vitro (e–g). (a) Teratoma showing derivatives of all three germ
layers. cre, ciliated respiratory epithelium, including inset at higher magnification showing cilia; int, intestinal epithelium; cart, cartilage; and ne, columnar neuro-
epithelium with associated retinal pigmented epithelium (rpe). (b–d) Examples from other teratomas: (b) bronchiolar nests, (c) muscle stained for smooth muscle
actin, and (d) intestinal epithelium stained for cdx2. (e–g) Examples of in vitro differentiated derivatives of clinical value: (e) hemangioblast colony with both hem-
atopoetic and endothelial potential, (f) an embryoid body with beating heart cells, and (g) retinal pigment epithelium. Scale bars, 100 mm.line, which is consistent with the low effi-
ciency previously reported (Klimanskaya
et al., 2006). However, in the second set
of experiments, 3 out of 15 embryos
(20%) generated stable hESC lines, a deri-
vation rate comparable with standard ESC
efficiency from blastocysts (Cowan et al.,
2004; Hovatta et al., 2003; Lanzendorf
et al., 2001; Simon et al., 2005; Thomson
et al., 1998).114 Cell Stem Cell 2, February 2008 ª2008When the blastomere-derived (hESC-
like) colonies reached 50 cells or more,
they were mechanically dispersed and
the clumps plated next to the initial
outgrowths. Secondary colonies were
also allowed to grow to a similar size and
mechanically passaged onto fresh MEFs
every 3–5 days until they adapted to rou-
tine passaging with trypsin and could be
frozen (usually after 7–10 passages)Elsevier Inc.as previously described (Klimanskaya
et al., 2007). At each passage, the colonies
were screened under a fluorescent
microscope for the absence of GFP-
positive cells. All four hESC lines were po-
sitive for Oct-4, Nanog, SSEA-3, SSEA-4,
TRA-1-60, TRA-1-81, and alkaline phos-
phatase (Figure 1B). In vitro differentiation
confirmed the presence of derivatives
from all three germ layers, including
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CorrespondenceFigure 2. Effects of Laminin on Single Blastomere Development and hESCs
(A–C) Formation of trophectoderm-like vesicles in the absence of laminin. (A) Hoffman modulation contrast, (B) immunostaining for cdx2, and (C) immunostaining
for cytokeratin 8.
(D–F) Formation of ICM-like outgrowth in the presence of laminin. (D) Phase contrast, (E) immunostaining for Oct-4, and (F) corresponding DAPI image.
(G–I) Depolarization effects of laminin on hESCs. (G and H) Confocal microscopy of the control (G) and laminin (H) overlaid hESC (WA07) costained with tight
junction marker ZO-1(green) and pluripotency marker Oct-4 (red). Ultrastructural analysis (semithin sections) of the cross section of the control (left) and laminin
overlaid (right) hESC colony (WA09). The control colony is organized into a semistratified epithelium. Presence of apical microvilli (mv) and tight junctions (data not
shown) indicate structural specialization typical for epithelial-like polarization. Laminin overlay induced cell depolarization as shown by lack of microvilli on the cell
surface and piling of cells to form multilayered structures. Scale bars, (A–H) 50 mm and (I) 7 mm.hematopoietic and endothelial cells, neu-
rons, retinal pigment epithelium (RPE),
beating heart cells, and other cell types
of therapeutic importance (Figure 1C). To
assess the in vivo differentiation potential,
the cells were injected under the kidney
capsules of NOD-SCID mice, where they
formed teratomas in7–12 weeks, differ-
entiating into structures of all three germ
layers (Figure 1B).
All four of the newly established hESC
lines had normal karyotypes (NED1, 46
XY; NED2, 46 XY; NED3, 46 XX; and
NED4, 46 XY (Figure S1). PCR analysis
confirmed the absence of GFP DNA,which eliminated the possibility of cross-
contamination or fusion with the GFP-
hESCs used for coculture (Figure S2).
Further genotyping showed the unique
identity of the new hESC lines, ruling out
any potential crosscontamination with
other hESC lines currently maintained in
our laboratory (Table S2).
Finally, in a third set of experiments, we
tested whether GFP-hESC coculture is
necessary for successful derivation. An
experiment was carried out with blasto-
meres removed from two frozen cleav-
age-stage embryos that were thawed
and cultured in blastocyst medium forCell Stem C2 hr prior to biopsy. A single blastomere
was removed from one embryo, and two
blastomeres were removed from the
second embryo. The remaining biopsied
embryos were allowed to continue devel-
opment and were frozen at the blasto-
cyst stage. Extracted blastomeres were
cultured under the same conditions as
described for the second set of experi-
ments except that no GFP-hESCs were
present. Both blastomere-derived aggre-
gates generated cellular outgrowths,
whereas one (50%) generated a stable
hESC line. Immunostaining of the stable
hESC line established from this colonyell 2, February 2008 ª2008 Elsevier Inc. 115
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markers of pluripotency, including Oct-4,
Nanog, SSEA-3, SSEA-4, TRA-1-60,
TRA-1-81, and alkaline phosphatase (Fig-
ure 1C). The newly established hESC line
had a normal male (46 XY) karyotype (Fig-
ure S1) and differentiated into derivatives
from all three germ layers, including im-
munostaining with antibodies to tubulin
b III (ectoderm), smooth muscle actin
(mesoderm), and a fetoprotein (primitive
endoderm).
Separate studies were carried out to
investigate the basis of enhanced blasto-
mere differentiation into ICM. In the
absence of laminin and fibronectin, di-
ssociated single blastomeres uniformly
differentiated into trophectoderm (16/16
[100%] of blastomere outgrowths con-
tained trophectodermal cells versus 0/16
[0%] ICM-like cells). By contrast, when
laminin was added to the medium, only
1/14 (7%) of blastomere-derived aggre-
gates gave rise to trophectoderm-like ves-
icles and 13/14 (93%) yielded ICM-like
cells. The addition of fibronectin alone
had little or no effect on lineage specifica-
tion (5/6 [83%] of outgrowths containing
trophectodermal cells versus 1/6 [17%]
ICM-like cells). This suggests that laminin
may play a key role in directing blastomere
differentiation toward ICM. To test this hy-
pothesis, we immunostained blastomere-
derived vesicles formed in the absence of
laminin (Figure 2A) and ICM-like cells
(Figure 2D) derived in the presence of lam-
inin for the markers of trophectoderm and
ICM/ESC, respectively. As expected,
blastomere-derived vesicles that formed
without laminin expressed key trophecto-
derm markers, including cdx2 and cyto-
keratin 8 (Figures 2B and 2C), whereas
ICM-like outgrowths formed in the pres-
ence of laminin, expressed Oct-4 (Fig-
ure 2E). Interestingly, immunostaining for
the tight junction marker ZO-1 and ultra-
structural analysis by transmission elec-
tron microscopy and semithin sections
(Krtolica et al., 2007; Figures 2G–2I) re-
vealed that the addition of laminin to the
culture medium of established hESC lines
disrupts tight junctions and depolarizes
ESCs, inducing them to assume an ICM-
like phenotype. Furthermore, staining for
ZO-1 confirmed that the addition of lami-
nin to the culture medium of the blasto-
meres disrupted tight junctions.
Since the publication of our previous
report showing the derivation of hESCs116 Cell Stem Cell 2, February 2008 ª2008 Efrom single blastomeres (Klimanskaya
et al., 2006), concerns have been raised
that none of the embryos used in the ex-
periments were allowed to develop and
that the survival of the biopsied embryos
was only demonstrated in control experi-
ments. Another concern was that several
(four to seven) blastomeres from each
embryo were cocultured together and
that this was essential to the successful
derivation of hESCs. And finally, there
were ethical objections that the derivation
system required coculture with hESCs
from other embryos that were destroyed.
Here we clearly show that hESC lines
can be derived without embryo destruc-
tion and that the biopsy procedure did
not appear to interfere with subsequent
good blastocyst development of the par-
ent embryo. These results were achieved
without culturing multiple blastomeres to-
gether, and at an efficiency substantially
higher (20% or 50% versus 2%) than in
our previous report. The success rate of
this new procedure is similar to that of
conventional hESC derivation techniques
using blastocysts. In addition, we show
that hESC coculture is not an essential
part of the derivation procedure.
Our current results demonstrate that
hESC lines can be generated far more
readily when the isolated blastomeres
are cultured in medium supplemented
with laminin. Laminin is a common com-
ponent of basement membranes (Aumail-
ley and Smyth, 1998), including those of
preimplantation embryos, and is associ-
ated with the induction of apical/basal
polarity (Bissell and Bilder, 2003; Klein
et al., 1988; Miner and Yurchenco, 2004;
Schuger et al., 1996). By exposing ex-
tracted blastomeres to laminin during
the first day of their postbiopsy develop-
ment, we enhanced their ability to give
rise to hESCs. We hypothesize that lami-
nin partially recapitulates the ICM niche
and suppresses trophectoderm differenti-
ation by preventing polarization of the
blastomeres. Indeed, our results demon-
strate that, unlike vesicles formed in the
absence of laminin, cell clumps formed
in the presence of laminin are not polar-
ized and express markers of ICM/ES
cells.
The stem cell lines generated in this
study appear to have the same character-
istics as other hESC lines, including ex-
pression of the same markers of pluripo-
tency, self-renewing capacity, karyotypiclsevier Inc.stability, and ability to differentiate into
derivatives of all three germ layers both
in vitro and in teratomas. The improved ef-
ficiency of the derivation procedure may
also allow translation of the technique to
the IVF clinic.
Supplemental Data
Supplemental Data include Supplemental Ex-
perimental Procedures, two figures, and two ta-
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